Endocrine & NutritionVideo course2026
11th Annual Diabetes, Obesity, & Metabolic Disease Conference 2026 — three days of cardiometabolic care
More than a third of Americans live with a cardiometabolic disorder. The 11th Annual Diabetes, Obesity, & Metabolic Disease Conference 2026, held at the Sheraton New Orleans on 1–3 May 2026, tackles them in three focused half-days, recorded as videos with slides: diabetes, the cardio-kidney-metabolic construct and MASLD with Vanita Aroda, Janani Rangaswami and Fernando Bril; obesity with Donna Ryan and Christopher Still; and the 2025 hypertension and 2026 lipid guidelines with John Basile and Laurence Sperling — each day ending in cases.
- 21sessions
- 7faculty
- 3half-day sessions
- May 2026recorded
What you’ll be able to do
- Deliver person-centred type 2 diabetes care
- Use combination therapy to protect heart and kidneys
- Identify and manage patients at risk for MASH
- Stage obesity and choose between incretins and surgery
- Apply the new hypertension and ACC/AHA lipid guidelines
Inside the course
11th Annual Diabetes, Obesity, & Metabolic Disease Conference 2026 by day
Diabetes, cardio-renal management and MASLD/MASH; comprehensive obesity management; then hypertension and dyslipidaemia — each with faculty Q&A and a case session.
Built for
- Primary care physiciansCardiometabolic risk in one course.
- NPs and PAsGuideline-based, case-driven teaching.
Faculty & programme
Day 1 — Diabetes, Cardio-Renal & MASLD 8 sessions
- V. Aroda — A Holistic Person-Centered Approach to Type 2 Diabetes Care
- J. Rangaswami — The Cardiovascular-Kidney-Metabolic Health Construct: Moving Away from Silos
- V. Aroda — Exploration of Gut Hormone Drugs: Current Status and Pipeline
- J. Rangaswami — Combination Therapies in Kidney Disease: Saving Lives, Hearts, and Kidneys
- J. Rangaswami, V. Aroda — Questions for Faculty
- J. Rangaswami, V. Aroda — Cases in Diabetes, Renal, and Cardio-Kidney Metabolic Disease
- F. Bril — Early Identification and Management of Individuals At-Risk for MASH
- F. Bril — Clinical Decision Making in MASLD/MASH: A Case-Based Approach
Day 2 — Comprehensive Obesity Management 7 sessions
- J. Basile — Day One Review
- D. Ryan — New Ways of Thinking About Obesity
- C. Still — Obesity: A Practical Guide to Diagnosis, Staging, and Front-Line Therapies
- C. Still — Metabolic and Bariatric Surgery: Is it Still an Option?
- D. Ryan — Incretins and Nutrient Stimulating Hormone Targeted Meds – Weight Loss and Beyond
- D. Ryan, C. Still — Questions for the Faculty
- D. Ryan, C. Still — Cases in Obesity Management
Day 3 — Hypertension & Dyslipidemia 6 sessions
- J. Basile — Day Two Review
- J. Basile — Clinical Pearls in Outpatient HTN: What’s New in the 2025 HTN Guideline
- L. Sperling — The 2026 Updated ACC/AHA Dyslipidemia Guideline: What’s New, What’s Not
- L. Sperling — Focus on Lipid-Related Risk as a Component of Comprehensive Cardio-Kidney-Metabolic Health
- J. Basile, L. Sperling — Questions for the Faculty
- J. Basile, L. Sperling — Cases on HTN and Lipids
Before you buy
Do I get CME credit or a certificate?
No. Clinicapedia provides the educational content only — no CME or CE credits, MOC points or certificates of completion are included with this product.
Specifications
| Format | Videos + slides |
|---|---|
| Contents | 21 sessions |
| Recorded | 1–3 May 2026, New Orleans |
| Department | Endocrine & Nutrition |
| Delivery | Instant download · lifetime re-download |


